ATP-activated decrosslinking and charge-reversal vectors for siRNA delivery and cancer therapy

about

ATP-activated decrosslinking and charge-reversal vectors for siRNA delivery and cancer therapy

Item

http://www.wikidata.org/entity/Q57116201

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

ATP-activated decrosslinking a ...... NA delivery and cancer therapy

@en

ATP-activated decrosslinking a ...... NA delivery and cancer therapy

@nl

type

Item

label

ATP-activated decrosslinking a ...... NA delivery and cancer therapy

@en

ATP-activated decrosslinking a ...... NA delivery and cancer therapy

@nl

prefLabel

ATP-activated decrosslinking a ...... NA delivery and cancer therapy

@en

ATP-activated decrosslinking a ...... NA delivery and cancer therapy

@nl

P1476

ATP-activated decrosslinking a ...... NA delivery and cancer therapy

@en

P2093

Chenggen Qian

http://www.w3.org/2001/XMLSchema#string

David Oupicky

http://www.w3.org/2001/XMLSchema#string

Gang Chen

http://www.w3.org/2001/XMLSchema#string

Huipeng Li

http://www.w3.org/2001/XMLSchema#string

Minghua Zhang

http://www.w3.org/2001/XMLSchema#string

Minjie Sun

http://www.w3.org/2001/XMLSchema#string

Qingyan Zhang

http://www.w3.org/2001/XMLSchema#string

Zhanwei Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

Physiological concentrations of purines and pyrimidines

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

Lipoic acid modified low molecular weight polyethylenimine mediates nontoxic and highly potent in vitro gene transfection.

ATP-Responsive and Near-Infrared-Emissive Nanocarriers for Anticancer Drug Delivery and Real-Time Imaging.

siRNA delivery systems for cancer treatment.

Systemic siRNA Delivery with a Dual pH-Responsive and Tumor-targeted Nanovector for Inhibiting Tumor Growth and Spontaneous Metastasis in Orthotopic Murine Model of Breast Carcinoma.

Tumor pH and its measurement.

RNA interference in the clinic: challenges and future directions.

Sialic Acid-Targeted Nanovectors with Phenylboronic Acid-Grafted Polyethylenimine Robustly Enhance siRNA-Based Cancer Therapy.

P304

4604-4619

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/THNO.26889

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30279726

http://www.w3.org/2001/XMLSchema#string

P932

6160761

http://www.w3.org/2001/XMLSchema#string